Anupam Rasayan India Ltd (ANURAS) Q1 FY27 Results Analysis: Revenue Surges 35%, Employee Costs Spike 219%

Anupam Rasayan India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 654.98 Cr (+34.82% YoY) and PAT growth of +5.69% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Consolidated revenue grew 34.82% YoY, driven by Jayhawk consolidation, but PAT growth was limited to 5.69% due to a 219% surge in employee costs. Standalone EBITDA margin improved to 33.28%, yet overall profitability remains under pressure from rising costs and credit rating watch on the Bliss GVS acquisition. Margin guidance was met, but execution cost risks persist.

Key Investment Insights

Key Positives

• Consolidated revenue grew 34.82% YoY to Rs.654.98 Cr, led by Jayhawk consolidation and organic volume growth.
• Standalone EBITDA margin expanded 342 bps YoY to 33.28%, supported by lower raw material costs.
• Raw material cost ratio declined 2,032 bps YoY to 54.03%, reflecting favorable input cost environment.
• Tanfac Industries delivered strong performance: revenue Rs.189.20 Cr and PAT Rs.16.85 Cr (8.9% PAT margin).
• Jayhawk acquisition accretive to consolidated EPS, which grew 9.35% YoY to Rs.3.39.

Risk Factors

• Employee costs surged 219.14% YoY to Rs.64.88 Cr, with subsidiary costs jumping 2.7x QoQ, indicating structural cost step-up.
• PAT growth (5.69%) lagged revenue growth (34.82%) significantly, highlighting margin compression from rising costs.
• Consolidated EBITDA margin contracted 79 bps YoY to 24.79% despite raw material tailwind.
• Credit ratings placed on watch with negative/developing implications due to Bliss GVS Pharma acquisition funding concerns.
• Doriath/Jayhawk group reported only 0.9% PAT margin, reflecting early-stage ramp-up costs and acquisition-related expenses.